Inovio Pharmaceuticals, Inc.
USD1.10
-0.01 (-1.34%)
CEO
Jacqueline E. Shea
IPO Date
1998-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.10
Prev. Close
$1.12
Day Low
$1.10
Day High
$1.12
52W Low
$1.03
52W High
$2.98
Market Cap
$0.06B
Volume
0.13M
| -0.5 |
| 31 Dec 2023 | FY | 100.0% | -16239.9% | -115.1% | -79.0% | 0.26 | 3.60 | -1.0 |
| 31 Dec 2022 | FY | 100.0% | -2726.7% | -125.8% | -80.3% | 0.14 | 3.25 | -1.3 |
| 31 Dec 2021 | FY | 100.0% | -17109.9% | -76.0% | -61.2% | 0.08 | 6.82 | -42.3 |
| 31 Dec 2020 | FY | 100.0% | -2245.4% | -36.1% | -30.8% | 0.08 | 11.30 | -105.5 |
| 31 Dec 2019 | FY | 100.0% | -2902.8% | -3474.7% | -82.9% | 28.97 | 2.94 | -41.3 |
| 31 Dec 2018 | FY | 100.0% | -318.1% | -111.5% | -74.0% | 0.00 | 2.49 | -45.7 |
| 31 Dec 2017 | FY | 100.0% | -208.9% | -61.9% | -47.1% | 0.00 | 3.91 | -45.9 |
| 31 Dec 2016 | FY | 100.0% | -208.5% | -59.8% | -42.5% | 0.00 | 2.84 | -82.5 |
| 54.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 589.3% | -65.6% | -1.30 | 0.79 | -0.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -82.4% | -34.5% | 0.37 | 1.66 | -0.8 |
| 31 Mar 2025 | Q1 | 100.0% | -30140.5% | -38.4% | -22.6% | 0.22 | 2.63 | -0.6 |
| 31 Dec 2024 | Q4 | -563.1% | -16566.4% | -28.3% | -17.1% | 0.17 | 2.77 | -0.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -34.2% | -23.5% | 0.17 | 3.88 | -1.6 |
| 30 Jun 2024 | Q2 | -722.4% | -31993.3% | -33.3% | -24.1% | 0.13 | 4.45 | -1.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -32.3% | -23.6% | 0.14 | 4.77 | -2.5 |
| 31 Dec 2023 | Q4 | -70.7% | -24357.9% | -21.3% | -14.6% | 0.26 | 3.60 | -1.4 |